Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR1 | P25024 | 7/20 | 0.39 |
| ▸ | CXCR2 | P25025 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CYP2J2 | P51589 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7862825 | 0.90 | P4HTM (0.43) | CXCR1CXCR2P4HTMGABRA5EPHX2 | |
| SCHEMBL7874627 | 0.85 | GABRA5 (0.43) | CXCR1CXCR2ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL9018098 | 0.84 | CXCR1 (0.44) | CXCR1CXCR2ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL7862789 | 0.84 | GABRA5 (0.45) | CXCR1CXCR2ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL7871594 | 0.82 | MMP8 (0.46) | ALDH1A1RAB9AP4HTMMAPT | |
| SCHEMBL9018431 | 0.82 | CXCR2 (0.47) | CXCR1CXCR2ALDH1A1RAB9AGABRA5 | |
| SCHEMBL7874244 | 0.81 | P4HTM (0.48) | CXCR2RAB9ASMN1; SMN2P4HTMGABRA5 | |
| SCHEMBL9018316 | 0.81 | CXCR1 (0.45) | CXCR1CXCR2ALDH1A1RAB9ASMN1; SMN2 | |
| SCHEMBL7867686 | 0.79 | P4HTM (0.58) | CXCR2RAB9ASMN1; SMN2P4HTMGABRA5 | |
| SCHEMBL7874552 | 0.79 | P4HTM (0.46) | RAB9ASMN1; SMN2P4HTMGABRA5EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0562512-B1 | Sulfonamidocarbonylpyridine-2-carboxamides and their use as medicines | HOECHST AG (DE) | 2001-02-21 | — | — | EP | disclosed |
| EP-0562512-A1 | Sulfonamido- and sulfonamidocarbonyl-pyridine-2-carboxamides and their pyridine-N-oxides, process for their preparation and their use as medicines | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-09-29 | — | — | EP | disclosed |